These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21346358)

  • 1. Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients.
    Salat D; Delgado P; Alonso S; Ribó M; Santamarina E; Quintana M; Alvarez-Sabín J; Montaner J
    Eur Neurol; 2011; 65(2):82-7. PubMed ID: 21346358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thrombolysis: the Bergen stroke study.
    Naess H; Idicula T; Lagallo N; Brogger J; Waje-Andreassen U; Thomassen L
    Acta Neurol Scand; 2010 Dec; 122(6):414-7. PubMed ID: 20199522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
    Kimura K; Iguchi Y; Shibazaki K; Aoki J; Watanabe M; Kobayashi K; Sakamoto Y
    Eur Neurol; 2010; 63(6):331-6. PubMed ID: 20516694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
    Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
    Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Belgian experience with intravenous thrombolysis for acute ischemic stroke.
    Vanacker P; Thijs V; Peeters A; Bruneel B; Laloux P; Druwé P; De Deyn P; Ahmed N; Wahlgren N; Vanhooren G;
    Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic ICH and outcomes in patients after IV tPA: a business of risk or risky business?
    Southerland AM; Malik S; Johnston KC
    Neurology; 2011 Jul; 77(4):315-6. PubMed ID: 21715703
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].
    Feuerhake W; Chamorro H; Araya F
    Rev Med Chil; 1999 Jul; 127(7):814-9. PubMed ID: 10668289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
    Liang BA; Lew R; Zivin JA
    Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 17. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
    Simon JE; Sandler DL; Pexman JH; Hill MD; Buchan AM;
    Age Ageing; 2004 Mar; 33(2):143-9. PubMed ID: 14960429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of MRI in the identification and treatment of early ischemic stroke lesions.
    O'Rourke F; Akhtar N; Emery D; Shuaib A
    CMAJ; 2004 Feb; 170(3):335-6. PubMed ID: 14757667
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of physiologic derangement in patients with stroke treated with thrombolysis.
    Idicula TT; Waje-Andreassen U; Brogger J; Naess H; Lundstadsveen MT; Thomassen L
    J Stroke Cerebrovasc Dis; 2008; 17(3):141-6. PubMed ID: 18436155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early hospital arrival improves outcome at discharge in ischemic but not hemorrhagic stroke: a prospective multicenter study.
    Naganuma M; Toyoda K; Nonogi H; Yokota C; Koga M; Yokoyama H; Okayama A; Naritomi H; Minematsu K
    Cerebrovasc Dis; 2009; 28(1):33-8. PubMed ID: 19420920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.